Skip to content

Top gainers Top losers Most active Market sectors Heatmap Treasury rates

Earnings calendar IPO calendar Ex-dividend calendar Economic calendar

Congress trades Insider trades Analyst upgrades & downgrades

Screener Compare Backtester

Valuation Fundamentals

Watchlist Portfolio

⌕/

Markets

Stocks Gainers Losers Most active Market sectors Heatmap Earnings calendar Congress trades Insider trades Analyst upgrades/downgrades IPO calendar Ex-dividend calendar

Tools

Screener Compare stocks Returns backtester Portfolio tracker Watchlist Embeddable widget

Metrics

Valuation Fundamentals

Popular lists

Best dividend stocks Best value stocks Largest companies Lowest P/E stocks

Collections

All lists & collections US stocks Japanese stocks Chinese stocks Hong Kong stocks South Korean stocks Taiwanese stocks Canadian stocks UK stocks European stocks Magnificent 7 AI stocks Semiconductor stocks

Compare

Compare stocks Finviz alternative Koyfin alternative TradingView alternative StockAnalysis alternative

Learn

Investing glossary Help & guide

StockMarketCapDocs Token Terms PrivacyData for information only, not investment advice.

◆

TG Therapeutics, Inc. (TGTX) News - StockMarketCap

Stocks›TG Therapeutics, Inc.☆

● At closeAs of Jul 2, 2026

TG Therapeutics, Inc.

TGTX✓

HealthcareBiotechnologyNASDAQ

$53.31-0.39%

$8.16BMarket cap

17.49xP/E ratio

3.04MVolume (24h)

Overview Forecast Valuation Financials Technical Dividends Smart money News

Price

$53.31

-$0.21 (-0.39%) · 24h

Key metrics

Market cap$8.16B+46.86%

Enterprise value$8.83B

Volume (24h)3.04M

P/E ratio (TTM)17.49x

P/S ratio (TTM)12.16x

Dividend yield0.00%

Shares outstanding153.08M

Trading range

Previous close$53.52

Day range$51.15 - $53.77

52-week range$25.28 - $57.38

TG Therapeutics, Inc. (TGTX) operates in the Biotechnology industry within the Healthcare sector, listed on NASDAQ.

Similar stocks

Eli Lilly and Company+1.57%

Johnson & Johnson+3.57%

AbbVie Inc.+3.99%

UnitedHealth Group Incorporated-0.28%

Roche Holding AG+3.89%

Merck & Co., Inc.+3.31%

Latest news